ESR1 and triple-negative breast carcinoma: In addition, AnAc 24:1n5 also inhibited the growth of MDA-MB-231 triple negative breast cancer (TNBC, i. e., ERα negative, progesterone receptor negative, and ERBB2 negative) cells, albeit at a higher IC50 and through an undefined mechanism [13].